@ Tranzyme Pharma raises $10M in stock sale | SEBIO

Tranzyme Pharma raises $10M in stock sale

Posted by on Sep 13, 2012

RESEARCH TRIANGLE PARK, NC – Tranzyme Pharma said Thursday that it has agreed to sell 2.6 million shares of its common stock at a price of $3.85 per share in a registered direct offering. The offering will raise gross proceeds to Tranzyme of $10 million before deducting underwriters’ discounts and other offering expenses. Tranzyme has also granted the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered to cover over-allotments, if any, which would result in additional gross proceeds of $1.5 million if exercised in full.


Leave a Reply